サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1505217

血小板由来成長因子（PDGFs）の世界市場：産業分析、規模、シェア、成長、動向、予測（2024～2032年）

Global Platelet-derived Growth Factors (PDGFs) Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 171 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
血小板由来成長因子（PDGFs）の世界市場：産業分析、規模、シェア、成長、動向、予測（2024～2032年）
出版日: 2024年06月01日
発行: Value Market Research
ページ情報: 英文 171 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血小板由来成長因子（PDGFs）の市場規模は、2023年に2億5,740万米ドルに達し、2024～2032年にかけてCAGR 7.51%で成長し、2032年にはほぼ4億9,390万米ドルに達すると予測されています。

血小板由来成長因子（PDGFs）は血小板に存在するタンパク質です。創傷治癒と組織再生に極めて重要であり、増殖、遊走、血管新生などの必須細胞機能に影響を与えます。傷害が起こると、血小板はPDGFsを放出し、線維芽細胞や平滑筋細胞などの組織修復に必要な細胞を引き寄せる。PDGFsは、慢性創傷、手術部位、整形外科的損傷などの治癒を促進する治療に治療的に用いられています。身体の自然治癒プロセスを促進することで、PDGFsは回復を早め、再生療法の成果を向上させます。

市場力学

血小板由来成長因子（PDGFs）市場は、創傷治癒と組織再生における重要な役割によって牽引されています。褥瘡や糖尿病性足潰瘍などの慢性創傷の急増が、PDGFsの需要を大幅に押し上げています。バイオテクノロジーの進歩は、より効果的で標的を絞ったPDGFs製剤の開発を可能にし、その治療の可能性を高めています。再生医療と組織工学技術の普及が、血小板由来成長因子（PDGFs）市場をさらに後押ししています。さらに、治癒プロセスを促進するPDGFsの特典に対する医療従事者の意識の高まりが、臨床現場での使用を促進しています。慢性創傷や手術の影響を受けやすい高齢者人口の拡大も、市場の成長に寄与しています。さらに、PDGFsの新たな用途の開拓を目的とした研究開発活動への多額の投資が、新たな成長機会を生み出すと期待されています。しかし、複雑な規制環境と高い生産コストが、今後数年間の血小板由来成長因子（PDGFs）市場成長の課題となる可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、産業の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、血小板由来成長因子（PDGFs）の世界市場における各セグメントを包括的に評価することもできます。血小板由来成長因子（PDGFs）産業の成長と動向は、この研究に全体的なアプローチを提供します。

市場セグメンテーション

血小板由来成長因子（PDGFs）市場レポートのこのセクションでは、国および地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家が今後の成長機会とともに、それぞれの製品またはサービスのターゲット層を特定するのに役立ちます。

タイプ別

  • PDGFs-AA
  • PDGFs-BB
  • PDGFs-CC
  • PDGFs-DD
  • PDGFs-AB

用途別

  • 整形外科
  • 心臓外科
  • がん治療
  • 創傷治癒
  • その他

エンドユーザー別

  • 病院
  • クリニック
  • その他

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける血小板由来成長因子（PDGFs）市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、本レポートでは、著名な全地域における個々の用途セグメントの需要・推定・予測に焦点を当てています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 血小板由来成長因子（PDGFs） - 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 世界の血小板由来成長因子（PDGFs）市場分析：タイプ別

  • 概要：タイプ別
  • 過去・予測データ分析：タイプ別
  • PDGFs-AA
  • PDGFs-BB
  • PDGFs-CC
  • PDGFs-DD
  • PDGFs-AB

第6章 世界の血小板由来成長因子（PDGFs）市場分析：用途別

  • 概要：用途別
  • 過去・予測データ分析：用途別
  • 整形外科
  • 心臓外科
  • がん治療
  • 創傷治癒
  • その他

第7章 世界の血小板由来成長因子（PDGFs）市場分析：エンドユーザー別

  • 概要：エンドユーザー別
  • 過去・予測データ分析：エンドユーザー別
  • 病院
  • クリニック
  • その他

第8章 世界の血小板由来成長因子（PDGFs）市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 血小板由来成長因子（PDGFs）企業の競合情勢

  • 血小板由来成長因子（PDGFs）市場競争
  • パートナーシップ／提携／合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.（PeproTech Inc.）
  • Stryker
  • Sigma-Aldrich（Merck KGaA）
  • OriGene Technologies
  • IXCells Biotechnologies
  • Abbexa Ltd
  • Bio-Techne
  • Stemcell Technologies
  • Neuromics
  • GenScript Biotech Corporation
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • PDGF-AA Market Sales By Geography (USD MN)
  • PDGF-BB Market Sales By Geography (USD MN)
  • PDGF-CC Market Sales By Geography (USD MN)
  • PDGF-DD Market Sales By Geography (USD MN)
  • PDGF-AB Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Orthopedic Surgeries Market Sales By Geography (USD MN)
  • Cardiac Surgeries Market Sales By Geography (USD MN)
  • Cancer Treatment Market Sales By Geography (USD MN)
  • Wound Healing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Platelet-derived Growth Factors (PDGFs) Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Platelet-derived Growth Factors (PDGFs) Report
  • Market Research Process
  • Market Research Methodology
  • Global Platelet-derived Growth Factors (PDGFs) Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • PDGF-AA Market Sales By Geography (USD MN)
  • PDGF-BB Market Sales By Geography (USD MN)
  • PDGF-CC Market Sales By Geography (USD MN)
  • PDGF-DD Market Sales By Geography (USD MN)
  • PDGF-AB Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Orthopedic Surgeries Market Sales By Geography (USD MN)
  • Cardiac Surgeries Market Sales By Geography (USD MN)
  • Cancer Treatment Market Sales By Geography (USD MN)
  • Wound Healing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112114931

The global demand for Platelet-derived Growth Factors (PDGFs) Market is presumed to reach the market size of nearly USD 493.9 Million by 2032 from USD 257.4 Million in 2023 with a CAGR of 7.51% under the study period 2024-2032.

Platelet-derived growth factors (PDGFs) are proteins present in platelets. They are pivotal for wound healing and tissue regeneration and influence essential cellular functions such as proliferation, migration, and angiogenesis. When an injury occurs, platelets release PDGFs to attract cells necessary for tissue repair, such as fibroblasts and smooth muscle cells. PDGFs are used therapeutically in treatments to enhance healing in chronic wounds, surgical sites, and orthopedic injuries. By promoting the body's natural healing processes, PDGFs help accelerate recovery and improve the outcomes of regenerative therapies.

MARKET DYNAMICS

The platelet-derived growth factors (PDGFs) market is driven by their critical role in wound healing and tissue regeneration. The surging incidence of chronic wounds, such as pressure sores and diabetic foot ulcers, has significantly boosted the demand for PDGFs. Advancements in biotechnology have enabled the development of more effective and targeted PDGF formulations, enhancing their therapeutic potential. The growing uptake of regenerative medicine and tissue engineering techniques further propels the platelet-derived growth factors (PDGFs) market. Additionally, the escalating awareness among healthcare professionals about the benefits of PDGFs in accelerating the healing process is driving their usage in clinical settings. The expanding elderly population, more susceptible to chronic wounds and surgeries, also contributes to market growth. Moreover, substantial investments in research and development activities aimed at exploring new applications of PDGFs are expected to create new growth opportunities. However, the complex regulatory environment and high production costs may challenge the platelet-derived growth factors (PDGFs)market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Platelet-derived Growth Factors (PDGFs). The growth and trends of Platelet-derived Growth Factors (PDGFs) industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Platelet-derived Growth Factors (PDGFs) market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • PDGF-AA
  • PDGF-BB
  • PDGF-CC
  • PDGF-DD
  • PDGF-AB

By Application

  • Orthopedic Surgeries
  • Cardiac Surgeries
  • Cancer Treatment
  • Wound Healing
  • Others

By End-User

  • Hospitals
  • Clinics
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Platelet-derived Growth Factors (PDGFs) market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Platelet-derived Growth Factors (PDGFs) market include Thermo Fisher Scientific Inc. (PeproTech Inc.), Stryker, Sigma-Aldrich (Merck KGaA), OriGene Technologies, IXCells Biotechnologies, Abbexa Ltd, Bio-Techne, Stemcell Technologies, Neuromics, GenScript Biotech Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PLATELET-DERIVED GROWTH FACTORS (PDGFS) - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PLATELET-DERIVED GROWTH FACTORS (PDGFS) MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. PDGF-AA Historic and Forecast Sales By Regions
  • 5.4. PDGF-BB Historic and Forecast Sales By Regions
  • 5.5. PDGF-CC Historic and Forecast Sales By Regions
  • 5.6. PDGF-DD Historic and Forecast Sales By Regions
  • 5.7. PDGF-AB Historic and Forecast Sales By Regions

6. GLOBAL PLATELET-DERIVED GROWTH FACTORS (PDGFS) MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Orthopedic Surgeries Historic and Forecast Sales By Regions
  • 6.4. Cardiac Surgeries Historic and Forecast Sales By Regions
  • 6.5. Cancer Treatment Historic and Forecast Sales By Regions
  • 6.6. Wound Healing Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PLATELET-DERIVED GROWTH FACTORS (PDGFS) MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-User
  • 7.2. Historical and Forecast Data Analysis By End-User
  • 7.3. Hospitals Historic and Forecast Sales By Regions
  • 7.4. Clinics Historic and Forecast Sales By Regions
  • 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL PLATELET-DERIVED GROWTH FACTORS (PDGFS) MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PLATELET-DERIVED GROWTH FACTORS (PDGFS) COMPANIES

  • 9.1. Platelet-derived Growth Factors (PDGFs) Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF PLATELET-DERIVED GROWTH FACTORS (PDGFS) INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Thermo Fisher Scientific Inc. (PeproTech Inc.)
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Stryker
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Sigma-Aldrich (Merck KGaA)
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. OriGene Technologies
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. IXCells Biotechnologies
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Abbexa Ltd
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Bio-Techne
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Stemcell Technologies
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Neuromics
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. GenScript Biotech Corporation
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies